Dexcom U.S. revenue (change on a year)
$83.33+2.38%
U.S. revenue (change on a year) at Dexcom came to 14% for the quarter to 30 Sep 2026, down 7.0 points from a year earlier.
As Dexcom reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 29 Oct 2026.
By quarter
| Period ending | U.S. revenue (change on a year) | Change on a year | Filed |
|---|---|---|---|
| 30 Sep 2026 | 14% | down 7.0 points | 29 Oct 2026 |
| 30 Jun 2026 | 11% | down 4.0 points | 30 Jul 2026 |
| 31 Mar 2026 | 11% | down 4.0 points | 30 Apr 2026 |
| 31 Dec 2025 | 11% | up 7.0 points | 12 Jan 2026 |
| 30 Sep 2025 | 21% | up 23.0 points | 30 Oct 2025 |
| 30 Jun 2025 | 15% | down 4.0 points | 30 Jul 2025 |
| 31 Mar 2025 | 15% | — | 1 May 2025 |
| 31 Dec 2024 | 4% | — | 13 Jan 2025 |
| 30 Sep 2024 | −2% | — | 24 Oct 2024 |
| 30 Jun 2024 | 19% | — | 25 Jul 2024 |
Definition
Revenue from this part of the business, as the company names and reports it in its results. Shown as the change on the same period a year earlier, as the company prints it. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.
Other operating KPIs of Dexcom: · financial statements
Every KPI and segment of DXCM, in the terminal.
Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.
